SCHEMBL2480102

SCHEMBL2480102

O=CCCC=O.O=CCCC=O

nearest known ligand 0.64

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.64
ALDH1A1 P00352 3/20 0.54
TSHR P16473 3/20 0.47
TDP1 Q9NUW8 2/20 0.44
MAPK1 P28482 1/20 0.42
FAAH O00519 2/20 0.35
TRPV1 Q8NER1 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35238 1.00
SCHEMBL5918577 1.00
SCHEMBL8464450 0.94
SCHEMBL7715168 0.94
SCHEMBL29159257 0.94
SCHEMBL10458830 0.94
SCHEMBL3294250 0.94
SCHEMBL9858051 0.94
SCHEMBL9301776 0.94
SCHEMBL11650194 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1531873-B1 AGENT DELIVERY PARTICLE BOSTON SCIENT LTD (BB) 2011-09-21 EP disclosed
EP-1531873-A2 AGENT DELIVERY PARTICLE Boston Scientific Limited (BB) 2005-05-25 EP disclosed
US-20040076582-A1 Agent delivery particle BOSTON SCIENTIFIC SCIMED, INC. 2004-04-22 US disclosed
WO-2004019999-A2 AGENT DELIVERY PARTICLE BOSTON SCIENTIFIC LIMITED (BB) 2004-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040076582-A1 Agent delivery particle TSG101, CD47, PAICS HIF1A 811/4885ALDH1A1 2216/4885TSHR 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.